| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.0088 | 1 |